Stay updated on Ladiratuzumab Vedotin for Advanced Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Ladiratuzumab Vedotin for Advanced Solid Tumors Clinical Trial page.

Latest updates to the Ladiratuzumab Vedotin for Advanced Solid Tumors Clinical Trial page
- Check2 days agoChange DetectedThe page shows a minor site version update with Revision: v3.4.2 added and Revision: v3.4.1 removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check9 days agoChange DetectedThe page revision label was updated from v3.4.0 to v3.4.1.SummaryDifference0.0%

- Check17 days agoNo Change Detected
- Check32 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4 on the page documentation.SummaryDifference0.0%

- Check53 days agoChange DetectedAdded a consolidated Locations section with a full list of participating sites by state/country (revision 3.3.3) and removed individual state location sections in favor of the unified list.SummaryDifference2%

- Check82 days agoChange DetectedRevision: v3.3.2 was added and v3.2.0 removed, reflecting a minor update to the page's version metadata without changes to study data or main content; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check89 days agoChange DetectedAdded a new study site in Tainan, Taiwan (70403) and updated the site name from Tainan City to Tainan. Removed the government funding status notice from the page.SummaryDifference0.2%

Stay in the know with updates to Ladiratuzumab Vedotin for Advanced Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ladiratuzumab Vedotin for Advanced Solid Tumors Clinical Trial page.